NEUMORA THERAPEUTICS INC (NMRA) Stock Analyst Earnings Estimates
NASDAQ:NMRA - Nasdaq - US6409791000 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 604.10% | N/A 93.28% | N/A 84.87% | N/A 60.37% | N/A 41.86% | N/A 33.56% | ||||||
| EBITDA YoY % growth | -20K | -25.39M -126,850.00% | -79.78M -214.22% | -122.28M -53.27% | -187.526M -53.36% | N/A -47.78% | N/A -3.34% | N/A 4.55% | N/A 40.90% | N/A 161.43% | N/A 222.61% | N/A 68.90% | N/A 37.38% | N/A 31.00% | |
| EBIT YoY % growth | -20K | -25.5M -127,400.00% | -80.32M -214.98% | -122.87M -52.98% | -188.194M -53.17% | N/A -48.66% | N/A -7.57% | N/A -11.27% | N/A 24.74% | N/A 56.82% | N/A 211.77% | N/A 301.13% | N/A 75.38% | N/A 54.38% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 8.50% | N/A -1.41% | N/A 2.00% | N/A 30.82% | N/A 80.55% | N/A 619.86% | N/A 137.53% | N/A 57.81% | N/A 34.93% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.45 36.17% | -0.45 -32.60% | -0.45 -22.95% | -0.43 4.80% | -0.40 11.09% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -81.6M -65.08% | -78.132M -30.40% | -80.988M -27.53% | -85.374M -12.08% | -91.902M -12.63% |
| EBIT Q2Q % growth | -76.841M -53.37% | -76.551M -27.43% | -79.203M -24.10% | -82.314M -7.40% | -82.416M -7.26% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.45 60.53% | -0.40 | -0.05 | -13.12% |
| Q2 2024 Q2Q % growth | -0.37 | -0.38 | 0.01 | 2.34% |
| Q1 2024 Q2Q % growth | -0.34 | -0.35 | 0.01 | 2.53% |
| Q4 2023 Q2Q % growth | -0.71 | -0.56 | -0.15 | -26.56% |
| Q3 2023 Q2Q % growth | -1.14 | -0.37 | -0.77 | -208.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -12.76% | 0.62% | -8.27% |
| Revenue | N/A | N/A | N/A | N/A |